Table 2.
Comparison of demographics and fracture characteristics between the two groups.
Variables | Overall (N = 1672) | Without DVT (N = 1549) | With DVT (N = 123) | P value |
---|---|---|---|---|
Age (> 70, years), n (%) | 1155 (69.1) | 1058 (68.3) | 97 (78.9) | 0.015 |
Gender (male), n (%) | 707 (42.3) | 656 (42.3) | 51 (41.5) | 0.848 |
Residential location (urban), n (%) | 749 (44.8) | 692 (44.7) | 57 (46.3) | 0.720 |
Hypertension, n (%) | 746 (44.6) | 694 (44.8) | 52 (42.3) | 0.587 |
Diabetes, n (%) | 342 (20.5) | 313 (20.2) | 29 (23.6) | 0.372 |
Cerebrovascular disease, n (%) | 515 (30.8) | 471 (30.4) | 44 (35.8) | 0.215 |
Cardiovascular disease, n (%) | 551 (33.0) | 502 (32.4) | 49 (39.8) | 0.009 |
Chronic respiratory disease, n (%) | 83 (5.0) | 79 (5.1) | 4 (3.3) | 0.364 |
Smoking history, n (%) | 113 (6.8) | 107 (6.9) | 6 (4.9) | 0.388 |
Preoperative systemic infection, n (%) | 41 (2.5) | 41 (2.6) | 0 (0.0) | 0.068 |
Tumors, n (%) | 36 (2.2) | 33 (2.1) | 3 (2.4) | 0.820 |
Traumatic brain injury, n (%) | 20 (1.2) | 16 (1.1) | 4 (3.3) | 0.029 |
Liver disease, n (%) | 36 (2.2) | 33 (2.1) | 3 (2.4) | 0.820 |
Renal disease, n (%) | 48 (2.9) | 47 (3.0) | 1 (0.8) | 0.156 |
Rheumatoid diseases, n (%) | 21 (1.3) | 20 (1.3) | 1 (0.8) | 0.647 |
Previous surgical history | 258 (15.4) | 234 (15.1) | 24 (19.5) | 0.193 |
Comorbidities (no.), n (%) | 0.004 | |||
0 | 323 (19.3) | 309 (19.9) | 14 (11.4) | |
1–2 | 758 (45.3) | 708 (45.7) | 50 (40.7) | |
≥ 3 | 591 (35.3) | 532 (34.3) | 59 (48.0) | |
ASA3–4, n (%) | 767 (45.9) | 707 (45.9) | 60 (48.8) | 0.891 |
BMI, n (%) | 0.664 | |||
< 18.5 | 93 (5.6) | 88 (5.7) | 5 (4.1) | |
18.5–23.9 | 1009 (60.3) | 939 (60.6) | 70 (56.9) | |
24–27.9 | 428 (25.6) | 394 (25.4) | 34 (27.6) | |
28–31.9 | 115 (6.9) | 104 (6.7) | 11 (8.9) | |
≥ 32 | 27 (1.6) | 24 (1.5) | 3 (2.4) | |
Injury mechanism (high energy), n (%) | 139 (8.3) | 126 (8.1) | 13 (10.6) | 0.346 |
Side (left), n (%) | 809 (48.4) | 707 (51.5) | 66 (53.7) | 0.637 |
ASA American Society of Anesthesiologists, BMI body mass index.